Journals / Türk Patoloji Dergisi / 2017 / Cilt: 33 - Sayı: 2

Intraductal Neoplasms of the Pancreas: An Update

Pages
87–102
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we provide an update into the most common intraductal neoplasms, namely intraductal papillary mucinous neoplasm and intraductal tubulopapillary neoplasm. we first focus on their clinicopathologic and molecular features of relevance to the practicing pathologist and then discuss their differential diagnoses.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:with improvements in imaging to detect silent pancreatic lesions and increases in the number of centers now performing pancreatic surgery, more surgeries have been performed for indications other than invasive carcinoma.
📊
Key Findings & Data:This has enormously added to our knowledge of the intraductal neoplasms of the pancreas.
💡
Conclusion & Impact:In this review, we provide an update into the most common intraductal neoplasms, namely intraductal papillary mucinous neoplasm and intraductal tubulopapillary neoplasm. we first focus on their clinicopathologic and molecular features of relevance to the practicing pathologist and then discuss their differential diagnoses.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

with improvements in imaging to detect silent pancreatic lesions and increases in the number of centers now performing pancreatic surgery, more surgeries have been performed for indications other than invasive carcinoma. This has enormously added to our knowledge of the intraductal neoplasms of the pancreas. In addition, our understanding of the genetics of these lesions has expanded with the introduction of routine molecular genetic analyses. In this review, we provide an update into the most common intraductal neoplasms, namely intraductal papillary mucinous neoplasm and intraductal tubulopapillary neoplasm. we first focus on their clinicopathologic and molecular features of relevance to the practicing pathologist and then discuss their differential diagnoses.

🔖

Cite This Article

BAŞTÜRK, O., MEMİŞ, B., BAĞCI, P., AŞKAN, G. (2022). Intraductal Neoplasms of the Pancreas: An Update. Türk Patoloji Dergisi, Cilt: 33 - Sayı: 2, 87–102. https://ajindex.com/articles/640503

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Klöppel G, Kosmahl M. Cystic lesions and neoplasms of the pancreas. The features are becoming clearer. Pancreatology. 2001;1:648-55
  2. Kosmahl M, Pauser U, Peters K, Sipos B, Lüttges J, Kremer B, Klöppel G. Cystic neoplasms of the pancreas and tumorlike lesions with cystic features: A review of 418 cases and a classification proposal. Virchows Arch. 2004;445:168-78
  3. Adsay NV. Cystic neoplasia of the pancreas: Pathology and biology. J Gastrointest Surg. 2008;12:401-4
  4. Spinelli KS, Fromwiller TE, Daniel RA, Kiely JM, Nakeeb A, Komorowski RA, Wilson SD, Pitt HA. Cystic pancreatic neoplasms: Observe or operate. Ann Surg. 2004;239:651-7; discussion 657-9
  5. Fernández-del Castillo C, Targarona J, Thayer SP, Rattner DW, Brugge WR, Warshaw AL. Incidental pancreatic cysts: Clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg. 2003;138:427-3; discussion 433-4
  6. Sessa F, Solcia E, Capella C, Bonato M, Scarpa A, Zamboni G, Pellegata NS, Ranzani GN, Rickaert F, Klöppel G. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: An investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch. 1994;425:357-67
  7. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S; International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32
  8. Adsay NV, Kloppel G, Fukushima N. WHO classification for tumors of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, editors. Intraductal neoplasms of the pancreas. Lyon:WHO;2010. 304-313
  9. Ingkakul T, Warshaw AL, Fernández-Del Castillo C. Epidemiology of intraductal papillary mucinous neoplasms of the pancreas: Sex differences between 3 geographic regions. Pancreas. 2011;40:779-80
  10. Fernández-del Castillo C, Adsay NV. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology. 2010;139:708-13, 713.e1-2
  11. Adsay NV. The "new kid on the block": Intraductal papillary mucinous neoplasms of the pancreas: Current concepts and controversies. Surgery. 2003;133:459-63
  12. Katabi N, Klimstra DS. Intraductal papillary mucinous neoplasms of the pancreas: Clinical and pathological features and diagnostic approach. J Clin Pathol. 2008;61:1303-13
  13. Nagai K, Doi R, Kida A, Kami K, Kawagu